Compliance and acceptance in antidepressant treatment

REFERENCES

• Blackwell B (1976) Treatment adherence. Br J Psychiatry 129: 513 -31.
   Google Scholar
• Lin EB, Von Korff M, Katon W et al (1995) The role of the primary care physician in patients adherence to antidepressant therapy. Med Care 33: 67 -74.
   Google Scholar
• Haynes RB, Sackett DB, Taylor DW (eds) (1979) Compliance in Health Care. Johns Hopkins University Press, Baltimore, MD: 2.
   Google Scholar
• Demyttenaere K (1997) Compliance during treatment with antidepressants. J Affect Disord 43: 27 - 39.
   Google Scholar
• Straka RJ, Fish JT, Benson SR, Suh JT (1997) Patient self- reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy 17: 126 - 32.
   Google Scholar
• Spector S, Kinsman R, Mawhinney H et al (1986) Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol 77: 65 - 70.
   Google Scholar
• Matsui D, Hermann C, Klein J et al (1994) Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. J Clin Pharmacol 34: 944 -9.
   Google Scholar
• Kass M, Gordon M, Meltzer D (1986) Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol 101: 524 -30.
   Google Scholar
• Kruse W, Weber E (1990) Dynamics of drug regimen compliance -its assessment by microprocessor-based monitoring. Eur J Pharmacol 38: 561 -5.
   Google Scholar
• George CF, Peveler RC, Heiliger S, Thompson C (2000) Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 50: 166 -71.
   Google Scholar
• Frank E, Perel JM, Mallinger AG et al (1992) Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression. Psychopharmacol Bull 28: 231 -5.
   Google Scholar
• Tollefson GD (1993) Adverse drug reactions/interactions in maintenance therapy. J Clin Psychiatry 4 (suppl): 48 -58.
   Google Scholar
• Altamura AC, Mauri M (1985) Plasma concentrations, information and therapy adherence during long-term treatment with antidepressants. Br J Clin Pharmacol 20: 714 -6.
   Google Scholar
• Cramer J, Vachon L, Desforges C, Sussman NM (1995) Dose frequency and dose interval compliance with multiple anti- epileptic medications during a controlled clinical trial. Epilepsia 36 (11): 1111–7.
   PubMed Web of Science ®Google Scholar
• Cramer JA (1995) Relationship between medication compliance and medical outcomes. Am J Health Syst Pharm 52 (suppl 3): S27 -9.
   Google Scholar
• Col N, Fanale JE, Kronholm P (1990) The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 150: 841 -5.
   Google Scholar
• Katon W, Von Korff M, Lin E et al (1992) Adequacy and duration of antidepressant treatment in primary care. Med Care 30: 67 -7.
   Google Scholar
• Simon GE, Von Korff M, Wagner EH, Barlow W (1993) Patterns of antidepressant use in community practice. Gen Hosp Psychiatry 15: 399 -408.
   Google Scholar
• Johnson DAW (1974) A study of the use of antidepressant medication in general practice. Br J Psychiatry 125: 186 -92.
   Google Scholar
• Maddox JC, Levi M, Thompson C (1994) The compliance with antidepressants in general practice. J Psychopharmacol 8 (suppl 1): 48 -53.
   Google Scholar
• Hylan TR, Dunn RL, Tepner RB, Meurgey F (1998) Gaps in antidepressant prescribing in primary care in the United Kingdom. Int Clin Psychopharmacol 13: 235 -43.
   Google Scholar
• Demyttenaere K, Van Ganse E, Gregoire J et al (1998) Compliance in depressed patients treated with fluoxetine or amitriptyline. Int Clin Psychopharmacol 13: 11 -17.
   Google Scholar
• Demyttenaere K (1998) Noncompliance with antidepressants: who’s to blame? Int Clin Psychopharmacol 13 (suppl 2): S19 -25.
   Google Scholar
• Fawcett J (1995) Compliance: definitions and key issues. J Clin Psychiatry 56 (suppl 1): 4 -8.
   Google Scholar
• Shaw E (1986) Lithium noncompliance. Psychiatr Ann 16 (suppl 10): 583 -8.
   Google Scholar
• Gitlin MJ, Cochran SD, Jamison KR (1989) Maintenance lithium treatment: side effects and compliance. J Clin Psychiatry 50: 127 -31.
   Google Scholar
• Demyttenaere K, Haddad P (2000) Compliance with anti- depressant therapy and antidepressant discontinuation symptoms. Acta Psychiatr Scand 101 (suppl 403): 50 -56.
   Google Scholar
• Demyttenaere K, Enzlin P, Dewe W et al (2001) Compliance with antidepressants in a primary care setting. (I): Beyond lack of efficacy and adverse events. J Clin Psychiatry (in press).
   Google Scholar
• Demyttenaere K, Enzlin P, Dewe W et al (2001) Compliance with antidepressants in a primary care setting. (II): Gender and the influence of impairment. J Clin Psychiatry (in press).
   Google Scholar
• Demyttenaere K, Mesters P, Boulanger B et al (2001) Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine. J Affect Dis (in press).
   Google Scholar
• George CF, Robertson D (1987) Clinical consequences of abrupt drug withdrawal. Med Tox Adv Drug Exp 2: 367 -82.
   Google Scholar
• Gardos G, Cole JO, Tarsy D (1978) Withdrawal syndromes associated with antipsychotic drugs. Am J Psychiatry 135: 1321–4.
   PubMed Web of Science ®Google Scholar
• Mander AJ, Loudon JB (1988) Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet ii: 15 -17.
   Google Scholar
• Coupland NJ, Bell CJ, Potokar JP (1996) Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 16: 356 -62.
   Google Scholar
• Girvin B, Johnston GD (1996) The implications of noncom- pliance with antihypertensive medication. Drugs 52: 186 -95.
   Google Scholar
• Mann AM, MacPherson AS (1959) Clinical experience with imipramine in the treatment of depression. J Can Psychiatr Assoc 4: 38 -47.
   Google Scholar
• Andersen H, Kristiansen ES (1959) Tofranil treatment of endogenous depressions. Acta Psychiatr Scand 34: 386 -97.
   Google Scholar
• Kramer JC, Klein DF, Fink K (1961) Withdrawal symptoms following discontinuation of imipramine therapy. Am J Psychiatry 118: 549 -50.
   Google Scholar
• Dilsaver SC, Greden JF (1984) Antidepressant withdrawal phenomena. Biol Psychiatry 19: 237 -56.
   Google Scholar
• Haddad P, Jejoyeux M, Young A (1998) Antidepressant discontinuation reactions. Br Med J 316: 1105–6.
   Google Scholar
• Price JS, Waller PC, Wood SM, MacKay AV (1996) A comparison of the post-marketing safety of four selective serotonin reuptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 42: 757 -63.
   Google Scholar
• Rosenbaum JF, Fava M, Hoog SL et al (1998) Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 44: 77 -87.
   Google Scholar
• Meichenbaum D, Turk DC (1987) Facilitating Treatment Adherence: A practitioner’s guidebook. Plenum Press, New York: 41.
   Google Scholar
• Basco MR (1993) Treatment Compliance in Affective Illness. A literature review commissioned by the Depression Guideline Panel, Depression in Primary Care, Vol. 2. Treatment of major depression. US Department of Health and Human Services, Public Health Service Agency for Health Care Policy and Research. Rockville MD
   Google Scholar
• Inui TS, Yourtee E, Williamson J (1976) Improved outcomes in hypertension after physician tutorials: a controlled trial. Ann Intern Med 84: 646 -51.
   Google Scholar
• Heszen-Klemens I (1987) Patients’ noncompliance and how doctors manage this. Soc Sci Med 24: 409 -16.
   Google Scholar
• Simon GE, Von Korff M, Rutter C, Wagner E (2000) Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. Br Med J 320: 550 -4.
   Google Scholar
• Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278 -96.
   PubMed Web of Science ®Google Scholar